Exploiting Genetic Interference for Antiviral Therapy.
Rapidly evolving viruses are a major threat to human health. Such viruses are often highly pathogenic (e.g., influenza virus, HIV, Ebola virus) and routinely circumvent therapeutic intervention through mutational escape. Error-prone genome replication generates heterogeneous viral populations that r...
Main Authors: | Elizabeth J Tanner, Karla A Kirkegaard, Leor S Weinberger |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-05-01
|
Series: | PLoS Genetics |
Online Access: | http://europepmc.org/articles/PMC4858160?pdf=render |
Similar Items
-
Dominant drug targets suppress the emergence of antiviral resistance
by: Elizabeth J Tanner, et al.
Published: (2014-11-01) -
The HSV-1 ICP4 Transcriptional Auto-Repression Circuit Functions as a Transcriptional “Accelerator” Circuit
by: Sonali Chaturvedi, et al.
Published: (2020-06-01) -
Conflicting Selection Pressures Will Constrain Viral Escape from Interfering Particles: Principles for Designing Resistance-Proof Antivirals.
by: Luke I Rast, et al.
Published: (2016-05-01) -
The promise and progress of RNA-interference-based antiviral therapy for respiratory syncytial virus.
by: V. V. Vysochinskayа, et al.
Published: (2014-09-01) -
RNA interference is the basis of human antiviral defense
by: J. N. Muratkhodjaev, et al.
Published: (2022-11-01)